🇺🇸 FDA
Pipeline program

Darvadstrocel

Darvadstrocel-3004

Approved mab terminated

Quick answer

Darvadstrocel for Crohn's Disease is a Approved program (mab) at Takeda with 3 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Crohn's Disease
Phase
Approved
Modality
mab
Status
terminated

Clinical trials